本文關鍵詞： 多囊卵巢綜合征 百令膠囊 達英- 糖代謝 尿酸　出處：《首都醫(yī)科大學學報》2016年04期 　論文類型：期刊論文

【摘要】：目的觀察百令膠囊輔助治療多囊卵巢綜合征(polycystic ovary syndrome,PCOS)的療效,研究其對糖脂代謝和肝腎功能的影響。方法將90例PCOS患者采用隨機數(shù)字表法隨機分為研究組(50例)和對照組(40例)。研究組采用達英-35聯(lián)合百令膠囊,對照組單用達英-35,觀察并比較兩組治療3個月前后空腹血糖(fasting plasma glucose,FPG)、空腹胰島素[fasting insulin,INS(OH)]、總膽固醇(total cholesterol,TC)、三酰甘油(triglyceride,TG)、高密度脂蛋白膽固醇(high density lipoproteincholesterol,HDL-C)、低密度脂蛋白膽固醇(low density lipoprotein-cholesterol,LDL-C)、載脂蛋白AI(apolipoprotein AI,Apo AI)、載脂蛋白B(apolipoprotein B,Apo B)、脂蛋白a[lipoprotein a,Lp(a)]、丙氨酸氨基轉(zhuǎn)移酶(alanine aminotransferase,ALT)、門冬氨酸氨基轉(zhuǎn)移酶(aspartate aminotransferase,AST)、r-谷氨酰轉(zhuǎn)移酶(gamma-glutamyl transpeptidase,GGT)、血肌酐(creatinine,Cr)、尿素氮(blood urea nitrogen,BUN)、尿酸(uric acid,UA)等一系列代謝指標的變化。結(jié)果 1治療后兩組TC均升高(P0.05),HDL-C輕度升高(P0.05);研究組TG濃度較對照組低(P0.05);研究組治療前后LDL-C差異無統(tǒng)計學意義,對照組顯著下降(P0.05);治療后兩組Apo AI、Apo B均升高,Lp(a)降低(P0.05),組間比較差異無統(tǒng)計學意義(P0.05)。2研究組FPG、胰島素抵抗較前降低(P0.05),空腹胰島素輕度降低(P0.05);研究組上述指標均較對照組低(P0.05)。3與治療前相比,研究組Cr和BUN差異無統(tǒng)計學意義(P0.05),UA降低(P0.05),對照組上述指標治療前后差異無統(tǒng)計學意義(P0.05);治療后研究組UA較對照組明顯降低,其余指標組間比較差異無統(tǒng)計學意義。4肝功能指標在組內(nèi)和組間比較差異無統(tǒng)計學意義。結(jié)論達英-35聯(lián)合百令膠囊治療PCOS患者能夠改善糖代謝和胰島素抵抗,對脂代謝有良好作用,保護腎功能,且對肝功能無不良影響。因此,百令膠囊能夠作為治療PCOS的輔助用藥。
[Abstract]:Objective to observe the efficacy of bailing capsule in the treatment of polycystic ovary syndrome (PCOS). Methods 90 patients with PCOS were randomly divided into study group (n = 50) and control group (n = 40). The study group was treated with dain-35 combined with bailing capsule. The control group was treated with dain-35 alone. The fasting plasma glucose and fasting insulin were observed and compared between the two groups before and after 3 months of treatment. [Total cholesterol (TC), total cholesterol (TC), triglyceride (triglyceride, triglyceride, triglyceride, triglyceride, triglyceride, triglyceride, triglyceride, triglyceride, triglyceride). High density lipoprotein cholesterol (HDL-C). Low density lipoprotein-cholesterol (LDL-C). Apolipoprotein AI(apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein, apolipoprotein A. [Lipoprotein, alanine aminotransferase, alanine aminotransferase, alanine aminotransferase, alanine aminotransferase, alanine aminotransferase, alanine aminotransferase (alt). Aspartate aminotransferase (AST). R-glutamyl transpeptidase (GGTN), creatinine creatinine (Cr). Urea nitrogen blood urea nitrogenin bun, uric acid uric acid. Results (1) after treatment, TC in both groups increased P0.05 and HDL-C increased slightly. The concentration of TG in the study group was lower than that in the control group (P 0.05). There was no significant difference in LDL-C before and after treatment in the study group, while in the control group it decreased significantly (P 0.05). After treatment, the Apo of the two groups increased significantly (P 0.05), and the FPG of the study group was not significantly different (P 0.05). Compared with the former, insulin resistance decreased P0.05A, fasting insulin decreased slightly (P0.05N). The above indexes in the study group were lower than those in the control group (P 0.053.Compared with those before treatment, there was no significant difference in Cr and BUN between the study group and the control group. In the control group, there was no significant difference between the above indexes before and after treatment (P 0.05). After treatment, UA in the study group was significantly lower than that in the control group. There was no significant difference in the other indexes between groups. 4. There was no significant difference in liver function between groups and within groups. Conclusion Dain-35 combined with Bering capsule can improve glucose metabolism and pancreas metabolism in patients with PCOS. Island resistance. It has good effect on lipid metabolism, protects renal function, and has no adverse effect on liver function. Therefore, bailing capsule can be used as an adjuvant drug in the treatment of PCOS.
【作者單位】： 首都醫(yī)科大學附屬北京婦產(chǎn)醫(yī)院內(nèi)分泌科;德國圖賓根大學婦產(chǎn)醫(yī)院絕經(jīng)內(nèi)分泌中心;
【基金】：北京市自然科學基金(Y161011) 北京市衛(wèi)生系統(tǒng)高層次衛(wèi)生技術(shù)人才(2014-2-016) 國家外國專家局2016年度北京市引進國外技術(shù)、管理人才項目(高外端)(20161100031) 首都醫(yī)科大學附屬北京婦產(chǎn)醫(yī)院,北京婦幼保健院學科帶頭人項目(2013-1)~~
【分類號】：R711.75
【正文快照】： 多囊卵巢綜合征(polycystic ovary syndrome,P-COS)是育齡期婦女最常見的內(nèi)分泌及代謝紊亂性疾病之一。PCOS表現(xiàn)具有高度異質(zhì)性,如月經(jīng)稀發(fā)或無排卵、多毛、痤瘡等,遠期合并癥包括肥胖、2型糖尿病、代謝綜合征、心血管疾病等。多項研究[1-2]顯示PCOS患者發(fā)生上述遠期合并癥的

【相似文獻】

相關期刊論文 前10條

1 曹黎明;;百令膠囊聯(lián)合纈沙坦治療糖尿病腎病臨床效果觀察[J];中國醫(yī)藥導刊;2012年09期

2 婁鵬華;龍新勝;李磊本;;纈沙坦聯(lián)合百令膠囊治療早期糖尿病腎病臨床觀察[J];實用醫(yī)學雜志;2010年20期

3 趙長江;劉建輝;唐文;王正良;;前列腺素E1聯(lián)合百令膠囊治療糖尿病腎病臨床觀察[J];南華大學學報(醫(yī)學版);2007年04期

4 黃毅嵐;楊虹;汪世梅;;百令膠囊治療早期糖尿病腎病的系統(tǒng)評價[J];中國藥業(yè);2012年20期

5 羅方;曹珊;孫新宇;;百令膠囊聯(lián)合厄貝沙坦治療早期糖尿病腎病的臨床研究[J];中醫(yī)學報;2011年04期

6 喬愛民;;替米沙坦聯(lián)合百令膠囊治療早期糖尿病腎病62例療效觀察[J];中國實用醫(yī)藥;2013年28期

7 王再紅;田孝平;郭琳;;降糖藥聯(lián)合百令膠囊治療糖尿病的療效觀察[J];中國誤診學雜志;2009年16期

8 陸玉蓮;;替米沙坦聯(lián)合百令膠囊治療糖尿病腎病療效觀察[J];臨床合理用藥雜志;2010年21期

9 陳發(fā)勝;百令膠囊治療Ⅱ型糖尿病腎病的臨床觀察[J];新中醫(yī);1997年03期

10 王位;;卡托普利聯(lián)合百令膠囊對糖尿病腎臟病微量白蛋白尿的影響[J];淮海醫(yī)藥;2012年02期

相關會議論文 前1條

1 孫奇華;王鈞;劉小蘭;章文俊;王瓊;;依那普利聯(lián)合百令膠囊治療老年早期糖尿病腎病療效觀察[A];2013年浙江省醫(yī)學會老年醫(yī)學學術(shù)年會暨國家級繼教項目老年人優(yōu)化健康管理研討班論文匯編[C];2013年

相關碩士學位論文 前3條

1 劉春燕;百令膠囊治療糖尿病腎病的臨床療效觀察[D];河北醫(yī)科大學;2015年

2 范莉萍;百令膠囊對橋本氏甲減免疫功能及甲狀腺功能的影響[D];吉林大學;2014年

3 劉萃;海昆腎喜膠囊和百令膠囊對尿酸性腎病的影響[D];青島大學;2014年

，

本文編號：1464124